Albumin-based biomaterial for lung tissue engineering applications

International Journal of Polymeric Materials and Polymeric Biomaterials

Volumn 65, Issue 16, 2016, Pages 853-861

  Aiyelabegan, Hammed T ^a   Zaidi, Sadaf S Z ^a   Fanuel, Songwe ^a   Eatemadi, Ali ^a   Ebadi, Malihe T K ^a   Sadroddiny, Esmaeil ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Albumin; lungs and biomaterial; regenerative medicine; scaffold; tissue engineering

Indexed keywords

BIOMATERIALS; SCAFFOLDS; TISSUE; TISSUE ENGINEERING;

ALBUMIN; DECELLULARIZED; MEDICAL TREATMENT; REGENERATIVE MEDICINE; SCAFFOLD FABRICATION; SUPPORT MATERIALS; SURFACTANT PROTEINS; TISSUE INTERACTIONS;

SCAFFOLDS (BIOLOGY);

EID: 84976581971     PISSN: 00914037     EISSN: 1563535X     Source Type: Journal    
DOI: 10.1080/00914037.2016.1180610     Document Type: Article

References (102)

1. R.Langer, ; J.P.Vacanti, Tissue engineering. Science 1993, 260, 920–926.
2. U.Meyer, ; T.Meyer, ; J.Handschel, ; H.-P.Wiesmann, (Eds.). Fundamentals of Tissue Engineering and Regenerative Medicine; Springer, New York, 2009.
3. H.C.Ott, ; T.S.Matthiesen, ; S.-K.Goh, ; L.D.Black, ; S.M.Kren, ; T.I.Netoff, ; D.A.Taylor, Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med. 2008, 14, 213–221.
4. H.C.Ott, ; B.Clippinger, ; C.Conrad, ; C.Schuetz, ; I.Pomerantseva, ; L.Ikonomou, ; D.Kotton, ; J.P.Vacanti, Regeneration, orthotopic transplantation of a bioartificial lung. Nat. Med. 2010, 16, 927–933.
5. B.E.Uygun, ; A.Soto-Gutierrez, ; H.Yagi, ; M.-L.Izamis, ; M.A.Guzzardi, ; C.Shulman, ; J.Milwid, ; N.Kobayashi, ; A.Tilles, ; F.Berthiaume, ; M.Hertl, ; Y.Nahmias, ; M.L.Yarmush, ; K.Uygun, Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 2010, 16, 814–820.
6. G.Orlando, ; A.C.Farney, ; S.S.Iskandar, ; H.-S.Mirmalek-Sani, ; D.C.Sullivan, ; E.Moran, ; T.AbouShwareb, ; D.C.Paolo, ; K.J.Wood, ; R.J.Stratta, ; A.Atala, ; J.J.Yoo, ; S.Soker, Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann. Surg. 2012, 256, 363–370.
7. J.Leor, ; Y.Amsalem, ; S.Cohen, Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Therap. 2005, 105, 151–163.
8. Y.Tabata, Biomaterial technology for tissue engineering applications. J. R. Soc. Interface 2009, 6, S311–S324.
9. Q.Shen, ; P.Shi, ; M.Gao, ; X.Yu, ; Y.Liu, ; L.Luo, ; Y.Zhu, Progress on materials and scaffold fabrications applied to esophageal tissue engineering. Mater. Sci. Eng. C 2013, 33, 1860–1866.
10. L.S.Nair, ; C.T.Laurencin, Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv. Biochem. Eng./Biotechnol. 2006, 102, 47–90.
11. B.D.Ratner, ; S.J.Bryant, Biomaterials: where we have been and where we are going. Ann. Rev. Biomed. Eng. 2004, 6, 41–75.
12. C.Oehr, Plasma surface modification of polymers for biomedical use. Nucl. Instr. Methods Phys. Res., Sect. B 2003, 208, 40–47.
13. H.McKellop, ; F.W.Shen, ; B.Lu, ; P.Campbell, ; R.Salovey, Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J. Orthop. Res. 1999, 17, 157–167.
14. D.Huh, ; B.D.Matthews, ; A.Mammoto, ; M.Montoya-Zavala, ; H.Y.Hsin, ; D.E.Ingber, Reconstituting organ-level lung functions on a chip. Science 2010, 328, 1662–1668.
15. R.Gauvin, ; A.Khademhosseini, Microscale technologies and modular approaches for tissue engineering: Moving toward the fabrication of complex functional structures. ACS Nano 2011, 5, 4258–4264.
16. X.Wang, ; H.J.Kim, ; C.Wong, ; C.Vepari, ; A.Matsumoto, ; D.L.Kaplan, Fibrous proteins and tissue engineering. Mater. Today 2006, 9, 44–53.
17. E.Hannachi Imen, ; M.Nakamura, ; M.Mie, ; E.Kobatake, Construction of multifunctional proteins for tissue engineering: epidermal growth factor with collagen binding and cell adhesive activities. J. Biotechnol. 2009, 139, 19–25.
18. F.Quaglia, Bioinspired tissue engineering: The great promise of protein delivery technologies. Int. J. Pharm. 2008, 364, 281–297.
19. X.Wang, ; E.Wenk, ; X.Hu, ; G.R.Castro, ; L.Meinel, ; X.Wang, ; C.Li, ; H.Merkle, ; D.L.Kaplan, Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 2007, 28, 4161–4169.
20. K.Kottke-Marchant, ; J.M.Anderson, ; Y.Umemura, ; R.E.Marchant, Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials 1989, 10, 147–155.
21. A.Maltais, ; G.E.Remondetto, ; M.Subirade, Soy protein cold-set hydrogels as controlled delivery devices for nutraceutical compounds. Food Hydrocoll. 2009, 23, 1647–1653.
22. E.T.Kang, ; Y.Zhang, Surface modification of fluoropolymers via molecular design. Adv. Mater. 2000, 12, 1481–1494.
23. Y.S.Lin, ; S.S.Wang, ; T.W.Chung, ; Y.H.Wang, ; S.H.Chiou, ; J.J.Hsu, ; N.K.Chou, ; T.H.Hsieh, ; S.H.Chu, Growth of endothelial cells on different concentrations of Gly- Arg-Gly-Asp photochemically grafted in polyethylene glycol modified polyurethane. Artif. Organs 2001, 25, 617–621.
24. V.Švorčík, ; V.Hnatowicz, ; P.Stopka, ; L.Bačáková, ; J.Heitz, ; R.Öchsner, ; H.Ryssel, Amino acids grafting of Ar+ions modified PE. Radiat. Phys. Chem. 2001, 60, 89–93.
25. M.Geiger, ; R.H.Li, ; W.Friess, Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 2003, 55, 1613–1629.
26. D.C.Carter, ; J.X.Ho, Structure of serum albumins. Adv. Protein Chem. 1994, 45, 153–203.
27. T.W.Evans, Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure. Aliment. Pharmacol. Ther. 2002, 16, 6–11.
28. J.P.Nicholson, ; M.R.Wolmarans, ; G.R.Park, The role of albumin in critical illness. Br. J. Anaesth. 2000, 85, 599–610.
29. P.-S.Li, ; I.-L.Lee, ; W.-L.Yu, ; J.-S.Sun, ; W.-N.Jane, ; H.-H.A.N.A.-B.T.S.F.A.T.E.A.Shen, H.-H. A novel albumin-based tissue scaffold for autogenic tissue engineering applications. Sci. Rep. 2014, 4, 5600.
30. G.Fanali, ; A.Di Masi, V.Trezza, ; M.Marino, ; M.Fasano, ; P.Ascenzi, Human serum albumin: From bench to bedside. Mol. Aspects Med. 2012, 33, 209–290.
31. R.Garcia-Martinez, ; P.Caraceni, ; M.Bernardi, ; P.Gines, ; V.Arroyo, ; R.Jalan, Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 2013, 58, 1836–1846.
32. K.Oettl, ; Stauber, R.E.;.P.C.I.T.R.S.O.H.S.A.C.I.I.B.P.Physiological, R. E.; pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 2007, 151, 580–590.
33. S.Sugio, ; A.Kashima, ; S.Mochizuki, ; M.Noda, ; K.Kobayashi, Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999, 12, 439–446.
34. T.-A.Chen, ; Y.-C.Tsao, ; A.Chen, ; G.-H.Lo, ; C.-K.Lin, ; H.-C.Yu, ; L.-C.Cheng, ; P.-I.Hsu, ; W.-L.Tsai, Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand. J. Gastroenterol. 2009, 44, 619–625.
35. S.N.Thung, ; D.F.Wang, ; T.M.Fasy, ; A.Hood, ; M.A.Gerber, Hepatitis B surface antigen binds to human serum albumin crosslinked by transglutaminase. Hepatology 1989, 9, 726–730.
36. D.Bosse, ; M.Praus, ; P.Kiessling, ; L.Nyman, ; C.Andresen, ; J.Waters, ; F.Schindel, Phase I comparability of recombinant human albumin and human serum albumin. J. Clin. Pharmacol. 2005, 45, 57–67.
37. B.Elsadek, ; F.Kratz, Impact of albumin on drug delivery - new applications on the horizon. J. Control. Release 2012, 157, 4–28.
38. T.Peters, Serum albumin. Adv. Protein Chem. 1985, 37, 161–245.
39. J.A.Huntington, ; P.E.Stein, Structure and properties of ovalbumin. J. Chromatogr. B Biomed. Sci. Appl. 2001, 756, 189–198.
40. L.T.Hunt, ; M.O.Dayhoff, A surprising new protein superfamily containing ovalbumin, antithrombin-III; & alpha 1-proteinase inhibitor. Biochem. Biophys. Res. Commun. 1980, 95, 864–871.
41. L.McReynolds, ; B.W.O’Malley, ; A.D.Nisbet, ; J.E.Fothergill, ; D.Givol, ; S.Fields, ; M.Robertson, ; G.G.Brownlee, Sequence of chicken ovalbumin mRNA. Nature 1978, 273, 723–728.
42. G.Chen, ; T.Ushida, ; T.Tateishi, Scaffold design for tissue engineering. Macromol. Biosci. 2002, 2, 67–77.
43. J.Zeltinger, ; J.K.Sherwood, ; D.A.Graham, ; R.Müeller, ; L.G.Griffith, Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001, 7, 557–572.
44. S.Fuchs, ; X.Jiang, ; H.Schmidt, ; E.Dohle, ; S.Ghanaati, ; C.Orth, ; A.Hofmann, ; A.Motta, ; C.Migliaresi, ; C.J.Kirkpatrick, Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 2009, 30, 1329–1338.
45. T.Osathanon, ; M.L.Linnes, ; R.M.Rajachar, ; B.D.Ratner, ; M.J.Somerman, ; C.M.Giachelli, Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials 2008, 29, 4091–4099.
46. S.Roche, ; M.C.Ronzière, ; D.Herbage, ; A.M.Freyria, Native and DPPA crosslinked collagen sponges seeded with fetal bovine epiphyseal chondrocytes used for cartilage tissue engineering. Biomaterials 2001, 22, 9–18.
47. J.J.Song, ; S.S.Kim, ; Z.Liu, ; J.C.Madsen, ; D.J.Mathisen, ; J.P.Vacanti, ; H.C.Ott, Enhanced in vivo function of bioartificial lungs in rats. Ann. Thorac. Surg. 2011, 92, 998–1006.
48. H.Liu, ; T.J.Webster, Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials 2007, 28, 354–369.
49. C.Z.Liu, ; Z.D.Xia, ; Z.W.Han, ; P.A.Hulley, ; J.T.Triffitt, ; J.T.Czernuszka, Novel 3D collagen scaffolds fabricated by indirect printing technique for tissue engineering. J. Biomed. Mater. Res. - Part B Appl. Biomater. 2008, 85, 519–528.
50. H.Yamazoe, ; T.Tanabe, Preparation of water-insoluble albumin film possessing nonadherent surface for cells and ligand binding ability. J. Biomed. Mater. Res. - Part A 2008, 86, 228–234.
51. H.Yamazoe, ; T.Uemura, ; T.Tanabe, Facile cell patterning on an albumin-coated surface. Langmuir 2008, 24, 8402–8404.
52. L.Gallego, ; L.Junquera, ; A.Meana, ; E.García, ; V.García, Three-dimensional culture of mandibular human osteoblasts on a novel albumin scaffold: growth, proliferation, and differentiation potential in vitro. Int. J. Oral Maxillofac. Implants 2009, 25, 699–705.
53. L.Gallego, ; L.Junquera, ; A.Meana, ; M.Alvarez-Viejo, ; M.Fresno, Ectopic bone formation from mandibular osteoblasts cultured in a novel human serum-derived albumin scaffold. J. Biomater. Appl. 2010, 25, 367–381.
54. L.Gallego, ; L.Junquera, ; E.García, ; V.García, ; M.Alvarez-Viejo, ; S.Costilla, ; M.F.Fresno, ; A.Meana, Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Eng. Part A 2010, 16, 1179–1187.
55. O.K.D.Yoon, ; B.Kang, ; Y.Kim, ; S.H.Lee, ; D.Rhew, ; W.H.Kim, Effect of serum-derived albumin scaffold and canine adipose tissue-derived 5 mesenchymal stem cells on osteogenesis in canine segmental bone defect model. J. Vet. Sci. 2015, 16, 397–404.
56. B.Kang, ; Y.Kim, ; S.H.Lee, ; W.H.Kim, ; H.Woo, Collagen I gel promotes homogenous osteogenic differentiation of adipose tissue-derived mesenchymal stem cells in serum-derived albumin scaffold. J. Biomater. Sci. Polym. Ed. 2013, 24, 1233–1243.
57. R.Rohanizadeh, ; N.Kokabi, Heat denatured/aggregated albumin-based biomaterial: Effects of preparation parameters on biodegradability and mechanical properties. J. Mater. Sci. Mater. Med. 2009, 20, 2413–2418.
58. N.Nseir, ; O.Regev, ; T.Kaully, ; J.Blumenthal, ; S.Levenberg, ; E.Zussman, Biodegradable scaffold fabricated of electrospun albumin fibers: mechanical and biological characterization. Tissue Eng. Part C Methods 2012, 19, 257–264.
59. S.Fleischer, ; A.Shapira, ; O.Regev, ; N.Nseir, ; E.Zussman, ; T.Dvir, Albumin fiber scaffolds for engineering functional cardiac tissues. Biotechnol. Bioeng. 2014, 111, 1246–1257.
60. H.-J.Wang, ; L.Di, ; Q.-S.Ren, ; J.-Y.Wang, Applications and degradation of proteins used as tissue engineering materials. Materials (Basel) 2009, 2, 613–635.
61. R.Parenteau-Bareil, ; R.Gauvin, ; F.Berthod, Collagen-based biomaterials for tissue engineering applications. Materials (Basel) 2010, 3, 1863–1887.
62. E.B.Breeze, ; R.G.Wheeldon, The cells of the pulmonary airways. Am. Rev. Respir. Dis. 1977, 116, 705–777.
63. K.H.Staub, ; N.C.Albertine, The structure of the lungs relative to their principal functions. In: Textbook of Respiratory Medicine, J.F.Murray J.A.Nadel editors. WB Saunders, Philadelphia, PA, 1988; pp. 12–36.
64. J.B.Richardson, ; C.C.Ferguson, Morphology of the airways. In: Lung Biology in Health and Disease: Physiology and Pharmacology of the Airwaves, J.A.Nadel editor. Marcel Dekker, New York, 1980; pp. 1–30.
65. A.Robbins, ; S.I.Rennard Biology of airway epithelial cells. In: The Lung: Scientific Foundations, R.G.Crystal J.B.West E.R.Weibel P.J.Barnes editors. Lippincott–Raven, Philadelphia, PA, 1996; pp. 445–457.
66. S.Shak, Mucins and lung secretions. In: The Lung: Scientific Foundations, R.G.Crystal J.B.West E.R.Weibel P.J.Barnes editors. Lippincott–Raven, Philadelphia, PA, 1996; pp. 479–486.
67. S.Hawgood, Surfactant: composition, structure, and metabolism. In: The Lung: Scientific Foundations, R.G.Crystal J.B.West E.R.Weibel P.J.Barnes editors. Lippincott–Raven, Philadelphia, PA, 1996; pp. 557–571.
68. R.L.Lubman, ; K.J.Kim, ; E.J.Crandall, Alveolar epithelial barrier properties. In: The Lung: Scientific Foundations, R.G.Crystal J.B.West E.R.Weibel P.J.Barnes editors. Lippincott–Raven, Philadelphia, PA, 1996; pp. 585–602.
69. R.J.King, ; D.J.Klass, ; E.G.Gikas, ; J.A.Clements, Isolation of apoproteins from canine surface active material. Am. J. Physiol. 1973, 224, 788–795.
70. R.T.White, ; D.Damm, ; J.Miller, ; K.Spratt, ; J.Schilling, ; S.Hawgood, ; B.Benson, ; B.Cordell, Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature 1985, 317, 361–363.
71. J.Floros, ; R.Steinbrink, ; K.Jacobs, ; D.Phelps, ; R.Kriz, ; M.Recny, ; L.Sultzman, ; S.Jones, ; H.W.Taeusch, ; H.A.Frank, Isolation characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J. Biol. Chem. 1987, 262, 12036–12043.
72. S.W.Glasser, ; T.R.Korfhagen, ; T.Weaver, ; T.Pilot-Matias, ; J.L.Fox, ; J.A.Whitsett, cDNA; and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe). Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 4007–4011.
73. S.Hawgood, ; B.J.Benson, ; J.Schilling, ; D.Damm, ; J.A.Clements, ; R.T.White, Nucleotide amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28–36 in surfactant lipid adsorption. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 66–70.
74. J.H.Fisher, ; J.M.Shannon, ; T.Hofmann, ; R.J.Mason, Nucleotide deduced amino acid sequence of the hydrophobic surfactant protein SP-C from rat: expression in alveolar type II cells and homology with SP-C from other species. Biochim. Biophys. Acta 1989, 995, 225–30.
75. R.G.Warr, ; S.Hawgood, ; D.I.Buckley, ; T.M.Crisp, ; J.Schilling, ; B.J.Benson, ; P.L.Ballard, ; J.A.Clements, ; R.T.White, Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 7915–7919.
76. A.Persson, ; D.Chang, ; K.Rust, ; M.Moxley, ; W.Longmore, ; E.Crouch, Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry 1989, 28, 6361–6367.
77. A.Persson, ; K.Rust, ; D.Chang, ; M.Moxley, ; W.Longmore, ; E.Crouch, CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins. Biochemistry 1988, 27, 8576–8584.
78. J.Lu, ; A.C.Willis, ; K.B.Reid, Purification, characterization and cDNA cloning of human lung surfactant protein D. J. Biochem. 1992, 284, 795–802.
79. J.Johansson, ; T.Curstedt, Molecular structures and interactions of pulmonary surfactant components. Eur. J. Biochem. 1997, 244, 675–693.
80. C.Grathwohl, ; G.E.Newman, ; P.J.R.Phizackerley, ; M.-H.S.S.O.L.O.B.I.F.P.L.Town, M.-H. Structural studies on lamellated osmiophilic bodies isolated from pig lung. 31P NMR results; and water content. Biochim. Biophys. Acta - Biomembr. 1979, 552, 509–518.
81. H.P.Haagsman, ; S.Hawgood, ; T.Sargeant, ; D.Buckley, ; R.T.White, ; K.Drickamer, ; B.J.Benson, The major lung surfactant protein, SP 28–36, is a calcium-dependent, carbohydrate-binding protein. J. Biol. Chem. 1987, 262, 13877–80.
82. J.S.Haurum, ; S.Thiel, ; H.P.Haagsman, ; S.B.Laursen, ; B.Larsen, ; J.C.Jensenius, Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem. J. 1993, 293, 873–878.
83. K.Drickamer, ; M.S.Dordal, ; L.M.-B.P.I.F.R.L.C.C.-R.D.L.T.C.T.Reynolds, L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J. Biol. Chem. 1986, 261, 6878–6887.
84. J.Lu, Collectins: collectors of microorganisms for the innate immune system. Bioessays 1997, 19, 509–518.
85. S.Thiel, ; K.B.Reid, Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett. 1989, 250, 78–84.
86. M.L.Nordlund, ;ersson, O.; R.Ahlgren, ; J.Schilling, ; M.Gillner, ; J.A.Gustafsson, ; J.Lund, Cloning, structure; and expression of a rat binding protein for polychlorinated biphenyls. Homology to the hormonally regulated progesterone-binding protein uteroglobin. J. Biol. Chem. 1990, 265, 12690–12693.
87. A.Bernard, ; H.Roels, ; R.Lauwerys, ; R.Witters, ; C.Gielens, ; A.Soumillion, ; J.Van Damme, ; M.De Ley, Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin. Chim. Acta 1992, 207, 239–249.
88. M.Martínez Sarrasague, ; A.Cimato, ; E.Rubin de Celis, ; G.Facorro, Influence of serum protein and albumin addition on the structure and activity of an exogenous pulmonary surfactant. Respir. Physiol. Neurobiol. 2011, 175, 316–21.
89. R.Cancedda, ; P.Giannoni, ; M.Mastrogiacomo, A tissue engineering approach to bone repair in large animal models; and in clinical practice. Biomaterials 2007, 28, 4240–4250.
90. A.J.Salgado, ; O.P.Coutinho, ; R.L.Reis, Bone tissue engineering: state of the art and future trends. Macromol. Biosci. 2004, 4, 743–65.
91. D.W.Hutmacher, Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21, 2529–2543.
92. C.Kim, ; Y.Lee, ; Y.Um, ; U.Jung, ; G.Chae, ; C.Kim, The effects of hydroxyapatite / calcium phosphate glass scaffold and its surface modification with bovine serum albumin on 1- wall intrabony defects of beagle dog: a preliminary study. Biomed. Mater. 2009, 3, 044113.
93. M.Weszl, ; G.Skaliczki, ; A.Cselenyák, ; L.Kiss, ; T.Major, ; K.Schandl, ; E.Bognár, ; G.Stadler, ; A.Peterbauer, ; L.Csönge, ; Z.Lacza, Freeze-dried human serum albumin improves the adherence and proliferation of mesenchymal stem cells on mineralized human bone allografts. J. Orthop. Res. 2012, 30, 489–496.
94. A.Ferrero-Gutierrez, ; Y.Menendez-Menendez, ; M.Alvarez-Viejo, ; A.Meana, ; J.Otero, New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats. Histol. Histopathol. 2013, 28, 89–100.
95. H.E.Olson, ; G.E.Rooney, ; L.Gross, ; J.J.Nesbitt, ; K.E.Galvin, ; A.Knight, ; B.Chen, ; M.J.Yaszemski, ; A.J.Windebank, Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng. Part A 2009, 15, 1797–1805.
96. K.S.Straley, ; C.W.P.Foo, ; S.C.Heilshorn, Biomaterial design strategies for the treatment of spinal cord injuries. J. Neurotrauma 2010, 27, 1–19.
97. E.R.Weibel, It takes more than cells to make a good lung. Am. J. Respir. Crit. Care Med. 2013, 187, 342–346.
98. D.E.Wagner, ; N.R.Bonenfant, ; C.S.Parsons, ; D.Sokocevic, ; E.M.Brooks, ; Z.D.Borg, ; M.J.Lathrop, ; J.D.Wallis, ; A.B.Daly, ; Y.W.Lam, ; B.Deng, ; M.J.DeSarno, ; T.Ashikaga, ; R.Loi, ; D.J.Weiss, Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 2014, 35, 3281–3297.
99. Z.Kolská, ; A.Řezníčková, ; M.Nagyová, ; N.Slepičková Kasálková, ; P.Sajdl, ; P.Slepička, ; V.Švorčík, Plasma activated polymers grafted with cysteamine improving surfaces cytocompatibility. Polym. Degrad. Stab. 2014, 101, 1–9.
100. N.Slepi, ; P.Slepi, ; P.Hoda, ; Š.Václav, Grafting of bovine serum albumin proteins on plasma-modified polymers for potential application in tissue engineering. Nanoscale Res. Lett. 2014, 9, 161.
101. S.E.Gilpin, ; J.P.Guyette, ; G.Gonzalez, ; X.Ren, ; J.M.Asara, ; D.J.Mathisen, ; J.P.Vacanti, ; H.C.Ott, Perfusion decellularization of human and porcine lungs: Bringing the matrix to clinical scale. J. Heart Lung Transplant. 2014, 33, 298–308.
102. K.M.Woo, ; V.J.Chen, ; P.X.Ma, Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J. Biomed. Mater. Res. A 2003, 67, 531–537.